Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 659206, 8 pages
http://dx.doi.org/10.1155/2014/659206
Review Article

Chemokines and Chemokine Receptors in Multiple Sclerosis

Department of Immunology and Microbiology, Shanghai JiaoTong University School of Medicine, Shanghai Institute of Immunology, Shanghai 200025, China

Received 29 July 2013; Accepted 18 December 2013; Published 2 January 2014

Academic Editor: Mohammad Athar

Copyright © 2014 Wenjing Cheng and Guangjie Chen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [43 citations]

The following is the list of published articles that have cited the current article.

  • Mohamad Raad, Eden Nohra, Nour Chams, Muhieddine Itani, Farid Talih, Stefania Mondello, and Firas Kobaissy, “Autoantibodies in Traumatic Brain Injury and Central Nervous System Trauma,” Neuroscience, 2014. View at Publisher · View at Google Scholar
  • Rune A Høglund, and Azzam A Maghazachi, “Multiple sclerosis and the role of immune cells.,” World journal of experimental medicine, vol. 4, no. 3, pp. 27–37, 2014. View at Publisher · View at Google Scholar
  • Wenjing Cheng, Qing Zhao, Yebin Xi, Chengzhen Li, Yunzhi Xu, Li Wang, Xiaoyin Niu, Zhaojun Wang, and Guangjie Chen, “IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis,” Molecular Immunology, 2014. View at Publisher · View at Google Scholar
  • Laurine Legroux, and Nathalie Arbour, “Multiple Sclerosis and T Lymphocytes: An Entangled Story,” Journal of Neuroimmune Pharmacology, 2015. View at Publisher · View at Google Scholar
  • Yonghao Cao, Brittany A. Goods, Khadir Raddassi, Gerald T. Nepom, William W. Kwok, J. Christopher Love, and David A. Hafler, “Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis,” Science Translational Medicine, vol. 7, no. 287, 2015. View at Publisher · View at Google Scholar
  • Nathan Karin, and Gizi Wildbaum, “The role of chemokines in adjusting the balance between CD4+ effector T cell subsets and FOXp3-negative regulatory T cells,” International Immunopharmacology, 2015. View at Publisher · View at Google Scholar
  • Hossein Khorramdelazad, Vahid Bagheri, Gholamhossein Hassanshahi, Masoud Zeinali, and Alireza Vakilian, “New insights into the role of stromal cell-derived factor 1 (SDF-1/CXCL12) in the pathophysiology of multiple sclerosis,” Journal of Neuroimmunology, 2015. View at Publisher · View at Google Scholar
  • Veit Rothhammer, and Francisco J. Quintana, “Control of autoimmune CNS inflammation by astrocytes,” Seminars In Immunopathology, vol. 37, no. 6, pp. 625–638, 2015. View at Publisher · View at Google Scholar
  • Jianhong Bao, Jinying Zhu, Sheng Luo, Ying Cheng, and Saijun Zhou, “CXCR7 suppression modulates microglial chemotaxis to ameliorate experimentally-induced autoimmune encephalomyelitis,” Biochemical and Biophysical Research Communications, 2015. View at Publisher · View at Google Scholar
  • Ghasem Ghalamfarsa, Mahmoud Mahmoudi, Mousa Mohammadnia-Afrouzi, Yaghoub Yazdani, Enayat Anvari, Abolghasem Hadinia, Amir Ghanbari, Maryam Setayesh, Mehdi Yousefi, and Farhad Jadidi-Niaragh, “IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis,” Journal of Immunotoxicology, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Stephani Velasquez, Eliana Scemes, Shaily Malik, Sarah E. Lutz, and Eliseo A. Eugenin, “Pannexin1 channels are required for chemokine-mediated migration of CD4+ T lymphocytes: Role in inflammation and experimental autoimmune encephalomyelitis,” Journal of Immunology, vol. 196, no. 10, pp. 4338–4347, 2016. View at Publisher · View at Google Scholar
  • Dandan Zhu, Jing Shan, Yuan Fan, and Juanyong Xu, “Changes of gene expression in T lymphocytes following Golli-MBP gene RNA interference,” Molecular Medicine Reports, vol. 14, no. 5, pp. 4575–4580, 2016. View at Publisher · View at Google Scholar
  • Gurbet Çelik Turgut, Doğukan Doyduk, Yılmaz Yıldırır, Serkan Yavuz, Atilla Akdemir, Ali Dişli, and Alaaddin Şen, “Computer design, synthesis, and bioactivity analyses of drugs like Fingolimod used in the treatment of Multiple Sclerosis,” Bioorganic & Medicinal Chemistry, 2016. View at Publisher · View at Google Scholar
  • Nadia Kavrochorianou, Maria Evangelidou, Melina Markogiannaki, Michael Tovey, George Thyphronitis, and Sylva Haralambous, “IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development,” Journal Of Leukocyte Biology, vol. 99, no. 1, pp. 175–188, 2016. View at Publisher · View at Google Scholar
  • Yakov Lomakin, Alexey Belogurov, Irina Glagoleva, Alexey Stepanov, Konstantin Zakharov, John Okunola, Ivan Smirnov, Dmitry Genkin, and Alexander Gabibov, “ Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF- α and IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients ,” Mediators of Inflammation, vol. 2016, pp. 1–8, 2016. View at Publisher · View at Google Scholar
  • Piotr Iwanowski, Jacek Losy, Lucyna Kramer, Marlena W?jcicka, and El?bieta Kaufman, “CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis,” Journal of the Neurological Sciences, 2017. View at Publisher · View at Google Scholar
  • Abdollah Jafarzadeh, Maryam Nemati, Zahra Arabi, Rayhaneh Ahangar-Parvin, and Marziyeh Mohammadi-Kordkhayli, “Ginger Extract Modulates the Expression of Chemokines CCL20 and CCL22 and Their Receptors (CCR6 and CCR4) in the Central Nervous System of Mice with Experimental Autoimmune Encephalomyelitis,” Drug Research, vol. 67, no. 11, pp. 632–639, 2017. View at Publisher · View at Google Scholar
  • Sergio M Pontejo, and Philip M Murphy, “Chemokines encoded by herpesviruses.,” Journal of leukocyte biology, vol. 102, no. 5, pp. 1199–1217, 2017. View at Publisher · View at Google Scholar
  • Bryan Nicol, Marion Salou, Isabel Vogel, Alexandra Garcia, Emilie Dugast, Jeremy Morille, Stéphanie Kilens, Eric Charpentier, Audrey Donnart, Steven Nedellec, Marylène Jacq-Foucher, Fabienne Le Frère, Sandrine Wiertlewski, Arnaud Bourreille, Sophie Brouard, Laure Michel, Laurent David, Pierre-Antoine Gourraud, Nicolas Degauque, Arnaud B. Nicot, Laureline Berthelot, and David-Axel Laplaud, “An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8 + T cells involved in multiple sclerosis,” Journal of Autoimmunity, 2017. View at Publisher · View at Google Scholar
  • Roberta Gualtierotti, Laura Guarnaccia, Matteo Beretta, Stefania E. Navone, Rolando Campanella, Laura Riboni, Paolo Rampini, and Giovanni Marfia, “Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids,” Advances in Therapy, vol. 34, no. 2, pp. 396–420, 2017. View at Publisher · View at Google Scholar
  • Yang Huang, Hongsong Yu, Qingfeng Cao, Jing Deng, Xinyue Huang, Aize Kijlstra, and Peizeng Yang, “The Association of Chemokine Gene Polymorphisms with VKH and Behcet’s Disease in a Chinese Han Population,” BioMed Research International, vol. 2017, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Abdollah Jafarzadeh, and Maryam Nemati, “Therapeutic potentials of ginger for treatment of Multiple sclerosis: A review with emphasis on its immunomodulatory, anti-inflammatory and anti-oxidative properties,” Journal of Neuroimmunology, 2018. View at Publisher · View at Google Scholar
  • Mohamad Karaky, María Fedetz, Victor Potenciano, Eduardo Andrés-León, Anna Esteve Codina, Cristina Barrionuevo, Antonio Alcina, and Fuencisla Matesanz, “SP140 regulates the expression of immune-related genes associated with multiple sclerosis and other autoimmune diseases by NF-κB inhibition,” Human Molecular Genetics, 2018. View at Publisher · View at Google Scholar
  • Anton Glasnović, Lidija DeŽmalj, Dominik Romić, Vjekoslav Jeleč, Ancrossed D Signelko Vrca, Maristela Stojić, Ivana D. Tudorić-Crossed Signeno, Vladimira Vuletić, and Danka Grčević, “RANKL/RANK/OPG Axis Is Deregulated in the Cerebrospinal Fluid of Multiple Sclerosis Patients at Clinical Onset,” NeuroImmunoModulation, vol. 25, no. 1, pp. 23–33, 2018. View at Publisher · View at Google Scholar
  • Yi Huang, Shite Hu, Yongliang Li, Dan Xue, and Xiuguo Wu, “Dexmedetomidine, an Alpha 2a Adrenergic Receptor Agonist, Mitigates Experimental Autoimmune Encephalomyelitis by Desensitization of CXCR7 in Microglia,” Biochemistry, 2018. View at Publisher · View at Google Scholar
  • Keqiang Chen, Zhiyao Bao, Teizo Yoshimura, Ji Ming Wang, Peng Tang, and Wanghua Gong, “Chemokines in homeostasis and diseases,” Cellular and Molecular Immunology, vol. 15, no. 4, pp. 324–334, 2018. View at Publisher · View at Google Scholar
  • Catherine E. Hughes, and Robert J. B. Nibbs, “A guide to chemokines and their receptors,” The FEBS Journal, 2018. View at Publisher · View at Google Scholar
  • Emma V. Bird, Tommaso Iannitti, Claire R. Christmas, Ilona Obara, Veselin I. Andreev, Anne E. King, and Fiona M. Boissonade, “A novel role for lymphotactin (XCL1) signalling in the nervous system: XCL1 acts via its receptor XCR1 to increase trigeminal neuronal excitability,” Neuroscience, 2018. View at Publisher · View at Google Scholar
  • Peng Xia, Xiaoting Gong, Lin Xiao, Yida Wang, Tianzhuo Zhang, Qingyuan Liao, Xiaoning Mo, Xiaoyan Qiu, and Jing Huang, “CCDC134 Ameliorated Experimental Autoimmune Encephalomyelitis by suppressing Th1 and Th17 cells,” Brain, Behavior, and Immunity, 2018. View at Publisher · View at Google Scholar
  • Andreia Monteiro, Catarina Cruto, Pedro Rosado, António Martinho, Luiza Rosado, Mafalda Fonseca, and Artur Paiva, “Characterization of circulating gamma-delta T cells in relapsing vs remission multiple sclerosis,” Journal of Neuroimmunology, 2018. View at Publisher · View at Google Scholar
  • Mohamed Oukka, and Estelle Bettelli, “Regulation of lymphocyte trafficking in central nervous system autoimmunity,” Current Opinion in Immunology, vol. 55, pp. 38–43, 2018. View at Publisher · View at Google Scholar
  • Susanna Esposito, Nicola Principi, Paolo Calabresi, and Donato Rigante, “An evolving redefinition of autoimmune encephalitis,” Autoimmunity Reviews, 2018. View at Publisher · View at Google Scholar
  • Kamayani Singh, James R. O. Eaton, Yara Alenazi, Graham Davies, Philip Elders, Akane Kawamura, and Shoumo Bhattacharya, “Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets,” Scientific Reports, vol. 8, no. 1, 2018. View at Publisher · View at Google Scholar
  • Qing Zhao, Wenjing Cheng, Yebin Xi, Zheyi Cao, Yunzhi Xu, Ting Wu, Chengzhen Li, Xiaoyin Niu, and Guangjie Chen, “IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis,” Molecular Immunology, vol. 93, pp. 20–30, 2018. View at Publisher · View at Google Scholar
  • Maxime De Laere, Zwi N Berneman, and Nathalie Cools, “To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis,” Journal of Neuropathology & Experimental Neurology, 2018. View at Publisher · View at Google Scholar
  • Maya Yamashita, Ken Ukibe, Yumi Matsubara, Tomohiro Hosoya, Fumihiko Sakai, Shigeyuki Kon, Yasunobu Arima, Masaaki Murakami, Hisako Nakagawa, and Tadaaki Miyazaki, “Lactobacillus helveticus SBT2171 Attenuates Experimental Autoimmune Encephalomyelitis in Mice,” Frontiers in Microbiology, vol. 8, 2018. View at Publisher · View at Google Scholar
  • Fumitaka Sato, Seiichi Omura, Nicholas E. Martinez, and Ikuo Tsunoda, “Animal Models of Multiple Sclerosis,” Neuroinflammation, pp. 37–72, 2018. View at Publisher · View at Google Scholar
  • Roy A. Garvin, “Treatment with relaxin reduces disease symptoms and enhances neuroprotection and remyelination in murine experimental autoimmune encephalomyelitis,” Italian Journal of Anatomy and Embryology, vol. 123, no. 1, pp. 64–79, 2018. View at Publisher · View at Google Scholar
  • Hossein Khanahmad, Ali Jahanian-Najafabadi, and Tahereh Sadeghian-Rizi, “Therapeutic targeting of chemokines and chemokine receptors in multiple sclerosis: Opportunities and challenges,” CNS and Neurological Disorders - Drug Targets, vol. 17, no. 7, pp. 496–508, 2018. View at Publisher · View at Google Scholar
  • Sheng Li, Yuqing Wu, Dongxue Yang, Chunyan Wu, Chunmei Ma, Xue Liu, Paul N. Moynagh, Bingwei Wang, Gang Hu, and Shuo Yang, “Gasdermin D in peripheral myeloid cells drives neuroinflammation in experimental autoimmune encephalomyelitis,” The Journal of Experimental Medicine, pp. jem.20190377, 2019. View at Publisher · View at Google Scholar
  • Hila Doron, Malak Amer, Nour Ershaid, Raquel Blazquez, Ophir Shani, Tzlil Gener Lahav, Noam Cohen, Omer Adler, Zahi Hakim, Sabina Pozzi, Anna Scomparin, Jonathan Cohen, Muhammad Yassin, Lea Monteran, Rachel Grossman, Galia Tsarfaty, Chen Luxenburg, Ronit Satchi-Fainaro, Tobias Pukrop, and Neta Erez, “Inflammatory Activation of Astrocytes Facilitates Melanoma Brain Tropism via the CXCL10-CXCR3 Signaling Axis,” Cell Reports, vol. 28, no. 7, pp. 1785–1798.e6, 2019. View at Publisher · View at Google Scholar
  • Camilla Thygesen, Martin Rössel Larsen, and Bente Finsen, “Proteomic signatures of neuroinflammation in Alzheimer’s disease, multiple sclerosis and ischemic stroke,” Expert Review of Proteomics, vol. 16, no. 7, pp. 601–611, 2019. View at Publisher · View at Google Scholar
  • Tiffany J. Petrisko, and Gregory W. Konat, “Peripheral viral challenge exacerbates experimental autoimmune encephalomyelitis,” Metabolic Brain Disease, 2019. View at Publisher · View at Google Scholar